Sharon Leonard, RD
Sharon Leonard has been a Registered Dietitian at the Center for Weight and Eating Disorders (CWED) for nearly 20 years. She received a B.S. in Food Science and Dietetics at Drexel University.
Sharon has conducted individualized and group weight loss counseling for grant and industry trials at CWED utilizing medication, behavioral, and dietary interventions. She has also provided nutrition assessments and counseling for Executive Health clients at Perelman. Her interests include helping patients identify the unique patterns and circumstances related to their food and nutrition behaviors in order to develop a practical and personalized meal plan that is consistent with their health goals.
Recent publications include:
- Wadden TA, Chao AM, Moore M, Tronieri JS, Gilden A, Amaro A, Leonard S, Jakicic JM. The Role of Lifestyle Modification with Second-Generation Anti-obesity Medications: Comparisons, Questions, and Clinical Opportunities. Curr Obes Rep. 2023 Dec;12(4):453-473. doi: 10.1007/s13679-023-00534-z. PMID: 38041774; PMCID: PMC10748770.
- Pearl RL, Wadden TA, Bach C, LaFata EM, Gautam S, Leonard S, Berkowitz RI, Latner JD, Jakicic JM. Long-term effects of an internalized weight stigma intervention: A randomized controlled trial. J Consult Clin Psychol. 2023 Jul;91(7):398-410. doi: 10.1037/ccp0000819. PMID: 37155264.
- Pearl RL, Wadden TA, Bach C, Gruber K, Leonard S, Walsh OA, Tronieri JS, Berkowitz RI. Effects of a cognitive-behavioral intervention targeting weight stigma: A randomized controlled trial. J Consult Clin Psychol. 2020 May;88 (5):470-480.
- Tronieri JS, Wadden TA, WalshO, Berkowitz RI, Alamuddin N, Gruber K, Leonard S, Bakizada ZM, Chao AM. Effects of liraglutide on appetite, food preoccupation, and food liking: results of a randomized controlled trial. Int J Obes (Lond). 2020 Feb;44(2):353-361.
- Tronieri JS, Wadden TA, Walsh OA, Berkowitz RI, Alamuddin N, Gruber K, Leonard S, Chao AM. Effects of liraglutide plus phentermine in adults with obesity following 1 year of treatment by liraglutide alone: A randomized placebo-controlled pilot trial. Metabolism. 2019 Jul;96:83-91.
Back to Top